SM
HIMS icon

Sciencast Management’s Hims & Hers Health HIMS Stock Holding History

Sciencast Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,600
Closed -$53K – 503
2022
Q1 		$53K Buy
+10,600
New +$52.4K 0.01% 495

Other funds holding HIMS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RM
Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return
IVMX
Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return
FVM
Forerunner Ventures Management San Francisco, California $169M AUM
NHSP
NewView HMS SPV Partners Burlingame, California $53.9M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Sciencast Management's HIMS Position: Q2 2022 in Review

Sciencast Management sold out of Hims & Hers Health (HIMS) in Q2 2022, closing a stake of 10,600 shares — an estimated $53K sold.

Sciencast Management first reported a position in HIMS in Q1 2022 and held it in 1 quarter. The position peaked at $53K in Q1 2022. 139 funds tracked by Wall St. Rank hold HIMS as of Q2 2022.

  • Sciencast Management reported no remaining Hims & Hers Health position as of Q2 2022 after selling out during the quarter.
  • Sciencast Management sold 10,600 Hims & Hers Health shares in Q2 2022, an estimated $53K.
  • Sciencast Management first reported a position in Hims & Hers Health in Q1 2022 and held it in 1 quarter.
  • Sciencast Management's Hims & Hers Health position peaked at $53K in Q1 2022.
  • 139 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.